Susquehanna International Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-255,154
| Closed | -$13.4M | – | 12146 |
|
|
2020
Q3 | $13.4M | Buy |
255,154
+188,872
| +285% | +$7.82M | ﹤0.01% | 1877 |
|
|
2020
Q2 | $2.21M | Sell |
66,282
-33,090
| -33% | -$1.05M | ﹤0.01% | 4317 |
|
|
2020
Q1 | $2.7M | Buy |
+99,372
| New | +$2.77M | ﹤0.01% | 3460 |
|
|
2019
Q4 | – | Sell |
-48,653
| Closed | -$778K | – | 11096 |
|
|
2019
Q3 | $631K | Sell |
48,653
-17,242
| -26% | -$208K | ﹤0.01% | 6753 |
|
|
2019
Q2 | $820K | Buy |
+65,895
| New | +$875K | ﹤0.01% | 6144 |
|
|
2017
Q1 | – | Sell |
-68,323
| Closed | -$1.07M | – | 10429 |
|
|
2016
Q4 | $1.03M | Buy |
+68,323
| New | +$902K | ﹤0.01% | 5482 |
|
|
2016
Q3 | – | Sell |
-14,001
| Closed | -$165K | – | 9323 |
|
|
2016
Q2 | $151K | Sell |
14,001
-19,980
| -59% | -$206K | ﹤0.01% | 7819 |
|
|
2016
Q1 | $314K | Buy |
33,981
+22,818
| +204% | +$246K | ﹤0.01% | 7192 |
|
|
2015
Q4 | $166K | Sell |
11,163
-45,217
| -80% | -$757K | ﹤0.01% | 8571 |
|
|
2015
Q3 | $925K | Buy |
56,380
+9,753
| +21% | +$200K | ﹤0.01% | 5923 |
|
|
2015
Q2 | $1.06M | Sell |
46,627
-183,422
| -80% | -$3.65M | ﹤0.01% | 6092 |
|
|
2015
Q1 | $3.5M | Buy |
230,049
+155,002
| +207% | +$2.01M | ﹤0.01% | 3280 |
|
|
2014
Q4 | $904K | Buy |
+75,047
| New | +$858K | ﹤0.01% | 6064 |
|
|
2014
Q3 | – | Sell |
-188,903
| Closed | -$2.15M | – | 10176 |
|
|
2014
Q2 | $2.28M | Buy |
188,903
+25,452
| +16% | +$301K | ﹤0.01% | 4409 |
|
|
2014
Q1 | $1.9M | Buy |
163,451
+96,275
| +143% | +$1.63M | ﹤0.01% | 4434 |
|
|
2013
Q4 | $1.19M | Buy |
67,176
+34,655
| +107% | +$582K | ﹤0.01% | 5189 |
|
|
2013
Q3 | $468K | Buy |
+32,521
| New | +$498K | ﹤0.01% | 6527 |
|
Susquehanna International Group's MNTA Position: Q4 2020 in Review
Susquehanna International Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 255,154 shares — an estimated $13.4M sold.
Susquehanna International Group first reported a position in MNTA in Q3 2013 and held it in 17 quarters. The position peaked at $13.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Susquehanna International Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 255,154 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.4M.
- Susquehanna International Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 17 quarters.
- Susquehanna International Group's Momenta Pharmaceuticals, Inc. position peaked at $13.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.